These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 7700380)

  • 1. CpG motifs in bacterial DNA trigger direct B-cell activation.
    Krieg AM; Yi AK; Matson S; Waldschmidt TJ; Bishop GA; Teasdale R; Koretzky GA; Klinman DM
    Nature; 1995 Apr; 374(6522):546-9. PubMed ID: 7700380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.
    Yi AK; Chace JH; Cowdery JS; Krieg AM
    J Immunol; 1996 Jan; 156(2):558-64. PubMed ID: 8543806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
    Ballas ZK; Rasmussen WL; Krieg AM
    J Immunol; 1996 Sep; 157(5):1840-5. PubMed ID: 8757300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.
    Yi AK; Klinman DM; Martin TL; Matson S; Krieg AM
    J Immunol; 1996 Dec; 157(12):5394-402. PubMed ID: 8955187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA.
    Krieg AM
    Trends Microbiol; 1996 Feb; 4(2):73-6. PubMed ID: 8820571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.
    Lipford GB; Bauer M; Blank C; Reiter R; Wagner H; Heeg K
    Eur J Immunol; 1997 Sep; 27(9):2340-4. PubMed ID: 9341778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
    Kim D; Jung J; Lee Y; Kwon HJ
    Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
    Jakob T; Walker PS; Krieg AM; Udey MC; Vogel JC
    J Immunol; 1998 Sep; 161(6):3042-9. PubMed ID: 9743369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogenicity of DNA from different organisms for murine B cells.
    Sun S; Beard C; Jaenisch R; Jones P; Sprent J
    J Immunol; 1997 Oct; 159(7):3119-25. PubMed ID: 9317108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant properties of CpG oligonucleotides in primates.
    Verthelyi D
    Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CpG dinucleotides in DNA vaccines.
    Krieg AM; Yi AK; Schorr J; Davis HL
    Trends Microbiol; 1998 Jan; 6(1):23-7. PubMed ID: 9481820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides.
    Redford TW; Yi AK; Ward CT; Krieg AM
    J Immunol; 1998 Oct; 161(8):3930-5. PubMed ID: 9780160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry.
    Yi AK; Chang M; Peckham DW; Krieg AM; Ashman RF
    J Immunol; 1998 Jun; 160(12):5898-906. PubMed ID: 9637502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Toll-like receptor recognizes bacterial DNA.
    Hemmi H; Takeuchi O; Kawai T; Kaisho T; Sato S; Sanjo H; Matsumoto M; Hoshino K; Wagner H; Takeda K; Akira S
    Nature; 2000 Dec; 408(6813):740-5. PubMed ID: 11130078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
    Chaung HC
    Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.
    Lee KW; Jung J; Lee Y; Kim TY; Choi SY; Park J; Kim DS; Kwon HJ
    Mol Immunol; 2006 May; 43(13):2107-18. PubMed ID: 16442622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
    Klinman DM; Yi AK; Beaucage SL; Conover J; Krieg AM
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2879-83. PubMed ID: 8610135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-rich DNA suppresses systemic lupus.
    Patole PS; Zecher D; Pawar RD; Gröne HJ; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2005 Nov; 16(11):3273-80. PubMed ID: 16176997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.